Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene

Title: Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene

Volume: 2 Issue: 1

Author(s): Zakir Khan, Pratiksha Bhadouria, Radha Gupta and Prakash S. Bisen

Affiliation:

Keywords: Survivin, IAPs, Apoptosis, Caspases, Ribozyme, p53

Abstract: Survivin is a relatively unique member of the inhibitor of apoptosis protein (IAP) family. It contains a single baculovirus IAP repeat (BIR) domain. It is involved in the control of cell cycle and inhibition of apoptosis. Survivin is of interest because it is specifically up-regulated in cancer cells and completely down-regulated and undetectable in normal adult tissues. Thus, survivin has proved to be a promising therapeutic target for normal anti-cancer therapy. Survivin protects the fast dividing tumor cells against default apoptosis to facilitate aberrant mitosis. Down-regulation of survivin with multiple approaches, suppress tumor progression and induce apoptosis on its own or in combination with chemotherapy and radiotherapy.

Cite this article as:

Khan Zakir, Bhadouria Pratiksha, Gupta Radha and Bisen S. Prakash, Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene, Current Cancer Therapy Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339406777592113